PharmAust Progresses to Elevated Doses of MPL in MND Patients Category: News and Announcements 2023By PharmAustJanuary 20, 2023Related postsFireside chat with Dr Roger AstonJanuary 17, 2023MND Trial Successfully Completes First Patient CohortJanuary 6, 2023